BackEver Supreme Bio Technology , Ltd Overview
Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology , Ltd Return on Equity

Ever Supreme Bio Technology , Ltd (6712.TWO) has a ROE of 16.5%, above the Healthcare sector average of 13.1%.

Get informed when a big investor buys or sells

+ Follow

ROE

16.50%

Return on Equity

16.50%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Ever Supreme Bio Technology , Ltd (6712.TWO) FAQ

Ever Supreme Bio Technology , Ltd posts a ROE of 16.5%. That is above the Healthcare sector average of 13.1%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a ROE near 13.1% is typical. Ever Supreme Bio Technology , Ltd's 16.5% is higher that level. That is roughly 25.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Ever Supreme Bio Technology , Ltd's ROE moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 16.5%; use YoY and peer views to separate noise from signal.

Context for 6712.TWO's ROE usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.1%), and (3) consistency with growth and profitability. This page covers the first two; Ever Supreme Bio Technology , Ltd's other metric pages and overview cover the third.

Judging Ever Supreme Bio Technology , Ltd against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in ROE easier to interpret. Start with 16.5% here, then scan peer and history charts to see if the gap is persistent.